ArticleThe Journal of clinical endocrinology and metabolism2014

Serum thyroglobulin (Tg) monitoring of patients with differentiated thyroid cancer using sensitive (second-generation) immunometric assays can be disrupted by false-negative and false-positive serum thyroglobulin autoantibody misclassifications.

Carole Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.